Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials
Ellingson, Benjamin M, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Zaw, Okkar, Mason, Warren P, Sahebjam, Solmaz, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Lai, Albert, Nghiemphu, Phioanh L, Pope, Whitney B, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Published in Neuro-oncology (Charlottesville, Va.) (01.01.2017)
Get full text
Journal Article
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Ellingson, Benjamin M, Gerstner, Elizabeth R, Smits, Marion, Huang, Raymond Y, Colen, Rivka, Abrey, Lauren E, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Chakhoyan, Ararat, Gahrmann, Renske, Pope, Whitney B, Leu, Kevin, Raymond, Catalina, Woodworth, Davis C, de Groot, John, Wen, Patrick Y, Batchelor, Tracy T, van den Bent, Martin J, Cloughesy, Timothy F
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Published in Neuro-oncology (Charlottesville, Va.) (03.09.2018)
Get full text
Journal Article
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody
Foon, Kenneth A, Yang, Xiao-Dong, Weiner, Louis M, Belldegrun, Arie S, Figlin, Robert A, Crawford, Jeffrey, Rowinsky, Eric K, Dutcher, Janice P, Vogelzang, Nicholas J, Gollub, Jared, Thompson, John A, Schwartz, Garry, Bukowski, Ronald M, Roskos, Lorin K, Schwab, Gisela M
Published in International journal of radiation oncology, biology, physics (01.03.2004)
Published in International journal of radiation oncology, biology, physics (01.03.2004)
Get full text
Journal Article
Conference Proceeding
Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
Schaffer, Elisabeth M, Basch, Ethan M, Schwab, Gisela M, Bennett, Antonia V
Published in Clinical trials (London, England) (01.08.2021)
Published in Clinical trials (London, England) (01.08.2021)
Get full text
Journal Article
The clinical pharmacology of therapeutic monoclonal antibodies
Roskos, Lorin K., Davis, C. Geoffrey, Schwab, Gisela M.
Published in Drug development research (01.03.2004)
Published in Drug development research (01.03.2004)
Get full text
Journal Article
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Powles, Thomas, Burotto, Mauricio, Escudier, Bernard, Bourlon, Maria T, Zurawski, Bogdan, Oyervides Juárez, Victor M, Hsieh, James J, Basso, Umberto, Shah, Amishi Y, Suárez, Cristina, Hamzaj, Alketa, Goh, Jeffrey C, Barrios, Carlos, Richardet, Martin, Porta, Camillo, Kowalyszyn, Rubén, Feregrino, Juan P, Żołnierek, Jakub, Pook, David, Kessler, Elizabeth R, Tomita, Yoshihiko, Mizuno, Ryuichi, Bedke, Jens, Zhang, Joshua, Maurer, Matthew A, Simsek, Burcin, Ejzykowicz, Flavia, Schwab, Gisela M, Apolo, Andrea B, Motzer, Robert J
Published in The New England journal of medicine (04.03.2021)
Published in The New England journal of medicine (04.03.2021)
Get full text
Journal Article
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article